July 30 (Reuters) -
Drugmaker AbbVie is in talks to acquire
privately-held mental health therapeutics company Gilgamesh
Pharmaceuticals in a deal worth about $1 billion, Bloomberg News
reported on Wednesday, citing people familiar with the matter.